Lilly Wollman

Company: Synteny

Job title: Chief Executive Officer

Seminars:

Pioneering Artificial Intelligence & Machine Learning to Turbocharge TCR Therapy Development 9:30 am

• Developing AI to rapidly screen TCR molecules to predict target binding • Accelerating screening of TCR libraries to identify effective TCR molecules with minimal off-target effects • Utilizing AI to influence the design for optimal synthetic TCR moleculesRead more

day: Day 2